Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Timken Company
TKR
$8.5B
| $22.4M | 0.04% |
611,254
+175,514
| +40% | +$7M |
|
577
Sun Communities
SUI
$15B
| $22.3M | 0.04% |
360,120
-32,524
| -8% | -$2.06M |
|
|
TRCO
578
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
| $22.2M | 0.04% |
415,806
+360,170
| +647% | +$20.1M |
|
579
First Interstate BancSystem
FIBK
$3.55B
| $22M | 0.04% |
793,320
+611,082
| +335% | +$16.9M |
|
|
BIG
580
DELISTED
Big Lots, Inc.
BIG
| $22M | 0.04% |
488,866
+45,856
| +10% | +$2.14M |
|
|
CAVM
581
DELISTED
Cavium, Inc.
CAVM
| $22M | 0.04% |
319,250
+240,793
| +307% | +$16.9M |
|
|
ENDP
582
DELISTED
Endo International plc
ENDP
| $21.9M | 0.04% |
275,533
+177,561
| +181% | +$15.3M |
|
|
OUTR
583
DELISTED
OUTERWALL INC
OUTR
| $21.9M | 0.04% |
287,533
-133,842
| -32% | -$9.77M |
|
|
AAWW
584
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $21.7M | 0.04% |
394,789
+226,307
| +134% | +$11.7M |
|
|
AMED
585
DELISTED
Amedisys
AMED
| $21.7M | 0.04% |
546,082
-229,762
| -30% | -$7.16M |
|
586
Olin
OLN
$2B
| $21.7M | 0.04% |
804,362
+194,439
| +32% | +$5.77M |
|
|
HNT
587
DELISTED
HEALTH NET INC
HNT
| $21.6M | 0.04% |
337,313
-693,742
| -67% | -$41.5M |
|
|
WBA
588
DELISTED
Walgreens Boots Alliance
WBA
| $21.6M | 0.04% |
256,139
-46,024
| -15% | -$3.97M |
|
|
KATE
589
DELISTED
Kate Spade & Company
KATE
| $21.6M | 0.04% |
+1,001,182
| New | +$29M |
|
590
United Therapeutics
UTHR
$22B
| $21.6M | 0.04% |
123,968
-102,711
| -45% | -$18.5M |
|
591
Adobe
ADBE
$110B
| $21.5M | 0.04% |
265,630
-456,939
| -63% | -$35.7M |
|
592
Oshkosh
OSK
$9.65B
| $21.5M | 0.04% |
+506,890
| New | +$25.4M |
|
593
Northern Trust
NTRS
$34.2B
| $21.4M | 0.04% |
279,949
+222,196
| +385% | +$16.6M |
|
|
CLR
594
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $21.4M | 0.04% |
503,751
+58,004
| +13% | +$2.76M |
|
595
Constellation Brands
STZ
$23.5B
| $21.3M | 0.04% |
183,892
+157,101
| +586% | +$18.5M |
|
|
HSP
596
DELISTED
HOSPIRA INC
HSP
| $21.3M | 0.04% |
240,303
-9,916
| -4% | -$873K |
|
597
AMN Healthcare
AMN
$1.34B
| $21.3M | 0.04% |
673,710
+102,821
| +18% | +$2.69M |
|
598
Silicon Motion
SIMO
$8.25B
| $21.3M | 0.04% |
614,338
+52,757
| +9% | +$1.72M |
|
|
SPR
599
DELISTED
Spirit AeroSystems
SPR
| $21.2M | 0.04% |
384,657
-289,949
| -43% | -$15.5M |
|
600
Ionis Pharmaceuticals
IONS
$10.3B
| $21.2M | 0.04% |
368,056
+361,256
| +5,313% | +$23M |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.